Heidi Capozzi previously served as chief people officer for McDonald’s.
Stock.adobe.com
CVS Health announced that Heidi Capozzi will serve as its new chief people officer.1 Prior to joining CVS Health, Capozzi was the chief people officer at McDonald’s and before that she worked at Boeing.
In a press release, Capozzi said, “I am excited to join CVS Health and be part of a team whose strategy is bold and necessary: redefining how health care is delivered in this country. I admire CVS Health for its leadership in imagining and delivering a personalized health care experience, and I am proud to join a company that is truly colleague and customer focused with a mission dedicated to improving health for everyone."
In the same press release, CVS Health president and CEO Karen S. Lynch said, “Heidi brings a depth of experience and a breadth of industry insights to CVS Health, in particular a proven track record of hiring, building, and growing strong teams and advancing a winning culture. From nimble startups to established brands, Heidi has consistently applied her expertise to championing talent and we look forward to her being a part of our leadership team."
CVS Health also recently announced that it had provided $525,000 in Health Zones funding to Central California Food Bank’s (CCFB) City Center Initiative.2
In a press release, CVS Health senior vice president of corporate social responsibility and chief sustainability officer Sheryl Burke said, “When people have access to supportive services, it puts them in a better position to take care of their health and well-being. Our Health Zones organizations in Fresno share our vision of improving health outcomes locally. We believe that by working together and integrating our other community-based efforts through programs like Project Health, we will make a meaningful impact and improve community health here in Fresno."
Central California Food Bank co-CEO Kym Dildine added, “Through this collaborative, the CVS Health Foundation is helping the incredible partners at City Center leverage food and nutrition to connect neighbors to a wide array of community supports that will improve overall health and well-being.”
Also in August, CVS Health announced a new environmental health initiative for people impacted by extreme weather events, such as deadly heat waves or powerful storms, both of which are becoming more common occurrences in the United States.3
In a press release, practicing physician and chief clinical innovation officer at CVS Caremark Dr. Dan Knecht said, “Extreme heat kills more Americans each year than all other weather events combined. In addition to fatalities driven by heat strokes, extreme heat can worsen chronic conditions such as cardiovascular disease, asthma and chronic obstructive pulmonary disease. Most heat-related deaths are preventable with outreach and intervention. We are proud to introduce a new capability that advances our efforts to find innovative ways to deliver personalized health care to consumers."
Asembia 2025: Therapy Advancements Highlight Growing Cost and Access Concerns
April 30th 2025Fran Gregory, VP, emerging therapies, Cardinal Health, discusses the evolving cell and gene therapy landscape, highlighting pipeline growth, cost challenges, and emerging therapeutic areas beyond oncology and hematology.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
FDA Approves AbbVie’s Rinvoq as First Oral JAK Inhibitor for Giant Cell Arteritis
April 30th 2025AbbVie secures FDA approval for Rinvoq as the first oral Janus kinase inhibitor indicated for giant cell arteritis, expanding its immunology portfolio and signaling strategic growth opportunities in underserved autoimmune markets.